A Phase I Trial of AVN944, an IMPDH Inhibitor, in Adults With Advanced Stage Solid Tumors

Clinical trial NCT00923728 · WITHDRAWN

Trial details

NCT number: NCT00923728
Sponsor: Vertex Pharmaceuticals Incorporated
Status: WITHDRAWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Refractory Solid Tumors

Start date: 2009-04-01
Primary completion: 2010-03-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.